Back
NovoCure Ltd. Vs. Perspective Therapeutics, Inc. Industry Stock Comparison
Sell
37
NVCR
NovoCure Ltd.
Last Price:
$13.78
Seasonality Move:
-7.29%
Sell
50
CATX
Perspective Therapeutics, Inc.
Last Price:
$2.7200
Seasonality Move:
35.57%
Sell
37
NovoCure Ltd. (NVCR)
is a Sell
Is NovoCure Ltd. a Buy, Sell or Hold?
-
The current NovoCure Ltd. [NVCR] share price is $13.77. The Score for NVCR is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
NVCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Perspective Therapeutics, Inc. (CATX)
is a Sell
Is Perspective Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Perspective Therapeutics, Inc. [CATX] share price is $2.7300. The Score for CATX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
CATX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVCR Stock Price Chart
What is NovoCure Ltd.'s stock price today?
-
The NovoCure Ltd. share price today is $13.77Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVCR is experiencing buying pressure, which is a positive indicator for future bullish movement.
CATX Stock Price Chart
What is Perspective Therapeutics, Inc.'s stock price today?
-
The Perspective Therapeutics, Inc. share price today is $2.7300The current trend is moderately bullish and CATX is experiencing slight buying pressure.
NVCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.28 | Buy |
| Relative Strength Index (14 RSI): | 60.79 | Buy |
| Chaikin Money Flow: | 825726 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.07 - 13.47) | Buy |
| Bollinger Bands (100): | (11.76 - 13.58) | Buy |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.07 | Buy |
| Relative Strength Index (14 RSI): | 53.21 | Buy |
| Chaikin Money Flow: | 87937 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.3736 - 2.8136) | Buy |
| Bollinger Bands (100): | (2.3665 - 3.7265) | Sell |
NVCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.35 | Buy |
| 20-day SMA: | 12.96 | Buy |
| 50-day SMA: | 12.5 | Buy |
| 200-day SMA: | 14.71 | Sell |
| 8-day EMA: | 13.28 | Buy |
| 20-day EMA: | 12.99 | Buy |
| 50-day EMA: | 12.79 | Buy |
| 200-day EMA: | 14.76 | Sell |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.77 | Sell |
| 20-day SMA: | 2.68 | Buy |
| 50-day SMA: | 2.5 | Buy |
| 200-day SMA: | 3.02 | Sell |
| 8-day EMA: | 2.75 | Sell |
| 20-day EMA: | 2.67 | Buy |
| 50-day EMA: | 2.71 | Buy |
| 200-day EMA: | 3.53 | Sell |
NovoCure Ltd. Earnings Growth & NVCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and an increase next year of $0.40 per share.
Perspective Therapeutics, Inc. Earnings Growth & CATX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.14 per share, and an increase next year of $0.17 per share.
NovoCure Ltd. Technical Analysis
| Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics, Inc. Technical Analysis
| Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | 02 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||